Due to the unprecedented nature of the COVID-19 pandemic, anyone reporting an Adverse Event and/or a Product Complaint via phone, should you receive a network busy signal (ie: if all lines busy/engaged) please continue to try your call throughout the day. Alternatively, you may email your Adverse Event to email@example.com OR Product Complaint to firstname.lastname@example.org, OR medical information request to MedInfo@propharmagroup.com.
PARAMUS, N.J., Jan. 15, 2019 /PRNewswire/ — WG Critical Care (WGCC), A Pharmasphere company, has launched the first and only FDA approved Calcium Gluconate in Sodium Chloride Injection in a Ready-To-Use Bag. “In addition to addressing a chronic drug shortage of this product, I’m excited to add another unique product to our expanding portfolio,” says...Read More
PARAMUS, N.J., March 1, 2018 /PRNewswire/ — WG Critical Care launched the first and only generic ready-to-use Esmolol HCl in Water for Injection (WFI), 2500 mg/250 mL (10 mg/mL) and Double Strength 2000 mg/100 mL (20 mg/mL). Esmolol is a cardiovascular agent indicated for rapid control of ventricular rate in patients with atrial fibrillation or...Read More
PARAMUS, N.J., Oct. 11, 2016 /PRNewswire/ — (WGCC), a wholly owned subsidiary of PharmaSphere, Inc., announced today that it has launched the first and only 400 mcg/4 mL and 1000 mcg/10 mL multi-dose vials. Dexmedetomidine HCl Injection is currently sold as a 2 mL vial by multiple manufacturers. Dexmedetomidine is also available in ready to...Read More